Other Guidelines | Page 31 | European Cystic Fibrosis Society (ECFS)

The effect of CFTR modulation with elexacaftor-tezacaftor-ivacaftor on the anxiety sweat rate in people with cystic fibrosis

A serious consideration about the wise use of the new, highly efficient, very expensive, treatment for cystic fibrosis (Trikafta©/Kaftrio©)

Immune response after COVID-19 vaccination in cystic fibrosis patients

Multi-Organ MRI in Cystic Fibrosis

How ivacaftor changes inflammation and protein levels in the bloodstream of people with CF and the G551D mutation

How the number of kinds of antibiotics chosen to treat Pseudomonas during an exacerbation affect recovery

What makes lung function fall between childhood and adolescence

Elexacaftor-Tezacaftor- Ivacaftor improves sinonasal sinus in cystic fibrosis

Intracranial mucous benign cyst causing bulging eye in a child with cystic fibrosis: a case report.

Reduced levels of nitric oxide in cystic fibrosis airways may be caused by interleukin-1 beta

first
previous
…
27
28
29
30
31
32
33
34
35
…
next
last